San Diego, CA, United States of America

Anna Maria Hedlund

This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: University of California. Active years: 2012-2014.


% Patents Active = 33.3


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 2012-2014

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Anna Maria Hedlund: Innovator in Transgenic Research

Introduction

Anna Maria Hedlund is a prominent inventor based in San Diego, CA. She has made significant contributions to the field of transgenic organisms and sialic acid chemistry. With a total of 3 patents, her work focuses on the elimination of N-glycolylneuraminic acid from animal products for human use.

Latest Patents

Hedlund's latest patent addresses the elimination of N-glycolylneuraminic acid from animal products for human use. This invention is particularly relevant in the field of transgenic (non-human) organisms, sialic acid chemistry, metabolism, and antigenicity. The method involves producing Neu5Gc-free animals by disrupting the CMAH gene, thereby reducing or eliminating Neu5Gc from biological material of non-humans.

Career Highlights

Anna Maria Hedlund is affiliated with the University of California, where she conducts her research. Her innovative work has garnered attention in the scientific community, contributing to advancements in the understanding of sialic acid and its implications for human health.

Collaborations

Hedlund has collaborated with notable researchers such as Ajit Varki and Dzung Nguyen. These partnerships have further enhanced her research and expanded the impact of her inventions.

Conclusion

Anna Maria Hedlund is a trailblazer in the field of transgenic research, with a focus on improving human health through innovative methods. Her contributions continue to shape the landscape of scientific inquiry and application.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…